---
figid: PMC4008642__nihms572820f1
figlink: /pmc/articles/PMC4008642/figure/F1/
number: Figure 1
caption: Growth factor mediated activation (EGF) of a receptor tyrosine kinase (EGFR)
  leads to downstream pathway signaling along the RAS-RAF-MEK-MAPK and PI3K-AKT-mTOR
  pathways. Key convergence points are MAPK mediated suppression of LKB1/AMPK energy
  sensing, and AKT activated translocation of the glucose transporter GLUT4 to the
  plasma membrane leading to augmented glucose import for anabolic (nucleotides, lipids,
  and amino acids) in addition to catabolism towards ATP regeneration in the mitochondria
  utilizing the proton gradient. Furthermore, MAPK stabilizes and mTOR increases translation
  of HIF1α, triggering the transcriptional function with effects on reducing pyruvate
  decarboxylation/oxidation to acetyl-CoA (Ac-CoA) destined for use in the TCA cycle.
  In melanoma cells, HIF1α activity reduces expression of MITF-PGC1α levels and thereby
  causes effects on reducing mitochondrial bioactivity (OXPHOS, ROS protection) in
  addition to differentiation associated cascades. Frequently mutant components (and
  pathways) in human cancers are indicted in red. Inhibitors of indicated pathway
  components are indicated in blue.
pmcid: PMC4008642
papertitle: 'Molecular Pathways: BRAF Induces Bioenergetic Adaptation by Attenuating
  Oxidative Phosphorylation.'
reftext: Rizwan Haq, et al. Clin Cancer Res. ;20(9):2257-2263.
pmc_ranked_result_index: '51877'
pathway_score: 0.9645653
filename: nihms572820f1.jpg
figtitle: 'Molecular Pathways: BRAF Induces Bioenergetic Adaptation by Attenuating
  Oxidative Phosphorylation'
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4008642__nihms572820f1.html
  '@type': Dataset
  description: Growth factor mediated activation (EGF) of a receptor tyrosine kinase
    (EGFR) leads to downstream pathway signaling along the RAS-RAF-MEK-MAPK and PI3K-AKT-mTOR
    pathways. Key convergence points are MAPK mediated suppression of LKB1/AMPK energy
    sensing, and AKT activated translocation of the glucose transporter GLUT4 to the
    plasma membrane leading to augmented glucose import for anabolic (nucleotides,
    lipids, and amino acids) in addition to catabolism towards ATP regeneration in
    the mitochondria utilizing the proton gradient. Furthermore, MAPK stabilizes and
    mTOR increases translation of HIF1α, triggering the transcriptional function with
    effects on reducing pyruvate decarboxylation/oxidation to acetyl-CoA (Ac-CoA)
    destined for use in the TCA cycle. In melanoma cells, HIF1α activity reduces expression
    of MITF-PGC1α levels and thereby causes effects on reducing mitochondrial bioactivity
    (OXPHOS, ROS protection) in addition to differentiation associated cascades. Frequently
    mutant components (and pathways) in human cancers are indicted in red. Inhibitors
    of indicated pathway components are indicated in blue.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - SLC2A4
  - AKT3
  - PRKAB2
  - DEC1
  - EGF
  - PRKAB1
  - AKT1
  - MAPK3
  - BRAF
  - MAPK9
  - MTOR
  - PIK3CD
  - PRKAG1
  - STK11
  - AIP
  - MAPK14
  - PIK3CG
  - PRKAA2
  - MITF
  - PIK3R5
  - PDK1
  - MAPK11
  - WDTC1
  - MFAP1
  - MAPK10
  - PIK3CA
  - AKT2
  - NRAS
  - MAP2K2
  - MAPK1
  - PRKAG3
  - PIK3R6
  - PTEN
  - PIK3R4
  - HRAS
  - PIK3R3
  - KRAS
  - MAPK8
  - PRKAG2
  - PIK3CB
  - MAP2K1
  - PRKAA1
  - MAPK12
  - MAPK13
  - Glucose
  - glucose
  - metformin
  - phenformin
  - pyruvate
  - 2,4-DNP
  - lactate
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Melanoma
genes:
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: GLUT4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: DEC1
  symbol: DEC1
  source: hgnc_symbol
  hgnc_symbol: DEC1
  entrez: '50514'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: LKB1
  symbol: LKB1
  source: hgnc_alias_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: AIP
  symbol: AIP
  source: hgnc_symbol
  hgnc_symbol: AIP
  entrez: '9049'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: MITF,
  symbol: MITF
  source: hgnc_symbol
  hgnc_symbol: MITF
  entrez: '4286'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: '[AMP]'
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAŞ
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: RAŞ
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: RAŞ
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
- word: glucose
  source: MESH
  identifier: D005947
- word: metformin
  source: MESH
  identifier: D008687
- word: phenformin
  source: MESH
  identifier: D010629
- word: pyruvate
  source: MESH
  identifier: D011773
- word: 2,4-DNP
  source: MESH
  identifier: D019297
- word: lactate
  source: MESH
  identifier: D019344
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
---
